Searching for experimental models of Pemphigus vulgaris

Archives of Dermatological Research

Volumn 299, Issue 1, 2007, Pages 9-12

  Cirillo, Nicola ^a   Gombos, Fernando ^a   Ruocco, Vincenzo ^a   Lanza, Alessandro ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; CYTOKINE; DESMOCOLLIN; DESMOGLEIN 1; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3; DESMOGLEIN 3 ANTIBODY; DESMOPLAKIN; EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MONOCLONAL ANTIBODY; PLAKOGLOBIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACANTHOLYSIS; APOPTOSIS; AUTOIMMUNITY; BLISTER; EXPERIMENTAL MODEL; HUMAN; IMMUNOPATHOGENESIS; NONHUMAN; PATHOPHYSIOLOGY; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOANTIBODIES; BLISTER; DESMOGLEIN 1; DESMOGLEIN 3; HUMANS; IMMUNOGLOBULIN G; MICE; MODELS, BIOLOGICAL; MODELS, THEORETICAL; PEMPHIGUS; RECEPTORS, CHOLINERGIC; SERUM;

EID: 34248184074     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-007-0733-1     Document Type: Short Survey

References (32)

1. Ahmed AR, Wagner R, Khatri K, Notani G, Awdeh Z, Alper CA, Yunis EJ (1991) Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with Pemphigus vulgaris. Proc Natl Acad Sci USA 88:5056-5060
2. Amagai M, Ahmed AR, Kitajima Y, Bystryn JC, Milner Y, Gniadecki R, Aoyama Y, Frusÿić-Zlotkin M, Muller E, David M, Mimouni D, Vind-Kezunovic D, Michel B, Mahoney M, Grando S (2006) Are desmoglein autoantibodies essential for the immunopathogenesis of Pemphigus vulgaris, or just "witnesses of disease"? Exp Dermatol 15:815-831
3. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA (1982) Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 306:1189-1196
4. Anhalt GJ, Till GO, Diaz LA, Labib RS, Patel HP, Eaglstein NF (1986) Defining the role of complement in experimental Pemphigus vulgaris in mice. J Immunol 137:2835-2840
5. Bhol KC, Rojas AI, Khan IU, Ahmed AR (2000) Presence of interleukin 10 in the serum and blister fluid of patients with Pemphigus vulgaris and pemphigoid. Cytokine 12:1076-1083
6. Cirillo N, Femiano F, Gombos F, Lanza A (2006) Serum from Pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes. FEBS Lett 580:3276-3281
7. Cirillo N, Gombos F, Lanza A (2006) Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity. J Cell Physiol 210:411-416
8. Cirillo N, Femiano F, Gombos F, Lanza A (2007) Metalloproteinase 9 is the outer executioner of desmoglein 3 in apoptotic keratinocytes. Oral Dis doi:10.1111/j.1601-0825.2006.01287.x
9. Cirillo N, Lanza A, Gombos F, Rossiello L, Lanza M (2007) Defining the involvement of proteinases in Pemphigus vulgaris: evidence of matrix metalloproteinase 9 overexpression in experimental models of disease. J Cell Physiol (in press)
10. Ding X, Diaz LA, Fairley JA, Giudice GJ, Liu Z (1999) The anti-desmoglein 1 autoantibodies in Pemphigus vulgaris sera are pathogenic. J Invest Dermatol 112:739-743
11. Dmochowski M, Hashimoto T, Garrod DR, Nishikawa T (1993) Desmocollins I and II are recognized by certain sera from patients with various types of Pemphigus particularly Brazilian Pemphigus foliaceus. J Invest Dermatol 100:380-384
12. Fan JL, Memar O, McCormick DJ, Prabhakar BS (1999) BALB/c mice produce blister-causing antibodies upon immunization with a recombinant human desmoglein 3. J Immunol 163:6228-6235
13. Farb RM, Dykes R, Lazarus GS (1978) Anti-epidermal-cell-surface Pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase. Proc Natl Acad Sci USA 75:459-463
14. Feliciani C, Toto P, Amerio P, Mohammad PS, Concione G, Shivji G, Wang B, Sauder DN (2000) In vitro and in vivo expression of interleukin-1α and tumor necrosis factor-α mRNA in Pemphigus vulgaris: interleukin-1α and tumor necrosis factor-α are involved in acantholysis. J Invest Dermatol 114:71-77
15. Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM (2001) The severity of cutaneous and oral Pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 144:775-780
16. Korman NJ, Eyre RW, Klaus-Kovtun V, Stanley JR (1989) Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of Pemphigus foliaceus and Pemphigus vulgaris. N Engl J Med 321:631-635
17. Kricheli D, David M, Frusic-Zlotkin M, Goldsmith D, Rabinov M, Sulkes J, Milner Y (2000) The distribution of Pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives. Br J Dermatol 143:337-342
18. Lanza A, Cirillo N, Femiano F, Gombos F (2006) How does acantholysis occur in Pemphigus vulgaris: a critical review. J Cutan Pathol 33:401-412
19. Lanza A, Femiano F, De Rosa A, Cammarota M, Lanza M, Cirillo N (2006) The N-terminal fraction of desmoglein 3 encompassing its immunodominant domain is present in human serum: implications for Pemphigus vulgaris autoimmunity. Int J Immunopathol Pharmacol 19:399-407
20. Lopez-Robles E, Avalos-Diaz E, Vega-Memije E, Hojyo-Tomoka T, Villalobos R, Fraire S, Domiguez-Soto L, Herrera-Esparza R (2001) TNF-α and IL-6 are mediators in the blistering process of Pemphigus. Int J Dermatol 40:185-188
21. Mimouni D, Foedinger D, Kouba DJ, Orlow SJ, Rappersberger K, Sciubba JJ, Nikolskaia OV, Cohen BA, Anhalt GJ, Nousari CH (2004) Mucosal dominant Pemphigus vulgaris with anti-desmoplakin autoantibodies. J Am Acad Dermatol 51:62-67
22. Nguyen VT, Ndoye A, Grando SA (2000) Novel human α9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. Am J Pathol 157:1377-1391
23. Nguyen VA, Ndoye A, Grando SA (2000) Pemphigus vulgaris antibody identifies pemphaxin, a novel keratinocyte annexin-like molecule binding acetylcholine. J Biol Chem 275:29466-29476
24. Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA (2000) Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce Pemphigus vulgaris-like lesions. J Clin Invest 106:1467-1479
25. Puviani M, Marconi A, Cozzani E, Pincelli C (2003) Fas ligand in Pemphigus sera induces keratinocyte apoptosis through the activation of caspase 8. J Invest Dermatol 120:164-167
26. Sekiguchi M, Futei Y, Fujii Y, Iwasaki T, Nishikawa T, Amagai M (2001) Dominant autoimmune epitopes recognized by Pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J Immunol 167:5439-5448
27. Tsunoda K, Ota T, Aoki M, Yamada T, Nagai T, Nakagawa T, Koyasu S, Nishikawa T, Amagai M (2003) Induction of Pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 170:2170-2178
28. Ueki H, Kohda M, Nobutoh T, Yamaguchi M, Omori K, Miyashita Y, Hashimoto T, Komai A, Tomokuni A, Ueki A (2001) Antidesmoglein autoantibodies in silicosis patients with no bullous diseases. Dermatology 202:16-21
29. Veldman CM, Gebhard KL, Uter W, Wassmuth R, Grotzinger J, Schultz E, Hertl M (2004) T cell recognition of desmoglein 3 peptides in patients with Pemphigus vulgaris and healthy individuals. J Immunol 172:3883-3892
30. Yeh SW, Cavacini LA, Bhol KC, Lin MS, Kumar M, Duval M, Posner MR, Ahmed AR (2006) Pathogenic human monoclonal antibody against desmoglein 3. Clin Immunol 120:68-75
31. Wang X, Bregegere F, Frusic-Zlotkin M, Feinmesser M, Michel B, Milner Y (2004) Possible apoptotic mechanism in epidermal cell acantholysis induced by Pemphigus vulgaris autoimmunoglobulins. Apoptosis 9:131-143
32. Williamson L, Raess NA, Caldelari R, Zakher A, de Bruin A, Posthaus H, Bolli R, Hunziker T, Suter MM, Muller EJ (2006) Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO J 25:3298-3309